Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
boston top stories
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
4
×
akcea therapeutics
alnylam pharmaceuticals
clinical trials
drugs
hereditary transthyretin amyloidosis
inotersen
patisiran
san diego blog main
san diego top stories
tafamidis
onpattro
pfizer
rna interference
san francisco blog main
san francisco top stories
vyndaqel
allopregnanolone
andrew fire
barry greene
biotech
boston university
brexanolone
craig mello
dan ollendorf
european medicines agency
harvard pilgrim health care
institute for clinical and economic review
john berk
john maraganore
marc goodman
marinus pharmaceuticals
What
fda
4
×
medicine
alnylam
drug
approved
rna
rnai
specifically
uses
afternoon
ago
alnylam’s
approve
approves
awaits
biological
brexanolone
cells
crossed
decades
decision
depression
devastating
discovered
disorder
ema
employ
europe
fast
fingers
follows
friday
gene
gets
harmful
historic
history
hits
interference
landmark
Language
Current search:
xconomy.com
×
" new york top stories "
×
fda
×
boston
×
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision